Top compounds associated with response to LRRTM1


Feature Type Standardized
Nominal ANOVA
mRNA SR-II-138A CTRPv2 pan-cancer AAC 0.038 0.2
mRNA KHS101 CTRPv2 pan-cancer AAC 0.045 0.2
mRNA YM-155 GDSC1000 pan-cancer AAC -0.041 0.2
mRNA Nutlin-3a (-) GDSC1000 pan-cancer AAC -0.042 0.2
mRNA NSC 74859 CTRPv2 pan-cancer AAC 0.046 0.2
mRNA Irinotecan CCLE pan-cancer AAC -0.064 0.2
mRNA tivozanib CTRPv2 pan-cancer AAC 0.044 0.2
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.044 0.2
mRNA Camptothecin GDSC1000 pan-cancer AAC -0.041 0.2
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.04 0.2
Download CSV